AN2 Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
AN2 Therapeutics Inc
TickerANTX
CIK #0001880438
CUSIP037326105
SectorLife Sciences - Pharmaceutical Preparations
Address1800 El Camino Real, Suite D, Menlo Park, CA 94027
Source [EDGAR]
CIK Filing 2011 - 2025
[0001880438] 10-K
[0001880438] 10-Q
[0001880438] 3
[0001880438] 4
[0001880438] 8-K
[0001880438] SC 13D
[0001880438] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Coastlands Capital Partners LP AN2 Therapeutics Inc [2025-06-04] 0.0
BML Investment Partners LP AN2 Therapeutics Inc [2025-05-07] 0.0
BML Investment Partners LP AN2 Therapeutics Inc [2024-08-12] 14.2
Octagon Capital Advisors LP AN2 Therapeutics Inc [2024-07-03] 10.1
Frazier Life Sciences Public Fund LP AN2 Therapeutics Inc [2024-04-10] 81942.4
Easom Eric AN2 Therapeutics Inc [2024-02-13] 81945.2
TCG Crossover GP I LLC AN2 Therapeutics Inc [2023-07-25] 6.6
Janus Henderson Group PLC AN2 Therapeutics Inc [2023-07-05] 5.1
Pfizer Inc AN2 Therapeutics Inc [2023-02-13] 7.02
BRII Biosciences Ltd AN2 Therapeutics Inc [2023-02-13] 5.4
Adjuvant Global Health Technology Fund LP AN2 Therapeutics Inc [2023-02-10] 11.3
RA Capital Management LP AN2 Therapeutics Inc [2022-04-08] 19.6
Citadel Advisors LLC AN2 Therapeutics Inc [2022-04-08] 7.1
Biotechnology Value Fund L P AN2 Therapeutics Inc [2022-04-04] 4.7
Form 3/4/5 Filer 2011 - 2025
Martin Patricia A.
AN2 Therapeutics, Inc.
Marks Gilbert Lynn
Aziz Kabeer
Leonard Braden Michael
Easom Eric
FitzPatrick Margaret M
Readnour Robin Shane
Zakrzewski Joseph S
Spigelman Melvin K
Wong Stephanie
Eizen Joshua M
Prior Stephen David
Chanda Sanjay
Day Lucy
RA Capital Management LP
Kolchinsky Peter
RA Capital Healthcare Fund LP
RA Capital Nexus Fund II, L.P.
Shah Rajeev M.
Krause Kevin Michael
Eckburg Paul
Adjuvant Global Health Technology Fund, L.P.
Adjuvant Global Health Technology Fund DE, L.P.
Adjuvant Capital GP, L.P.
Adjuvant Capital Management, LLC
Nazak Michael Adrian
Form 13F Holdings
Firm Period DFND Voting Shares
Almitas Capital LLC [2025-06-30] SOLE 1,428,323 1,428,323
Vanguard Group Inc [2025-06-30] SOLE 0 1,028,613
Pfizer Inc [2025-06-30] DFND 0 715,295
Peapod Lane Capital LLC [2025-06-30] SOLE 466,527 582,770
Stonepine Capital Management LLC [2025-06-30] SOLE 544,494 544,494
Bank of Nova Scotia [2025-06-30] SOLE 459,194 459,194
Bank of Montreal /Can/ [2025-06-30] DFND 422,077 422,077
Renaissance Technologies LLC [2025-06-30] SOLE 398,854 398,854
Bank of America Corp /DE/ [2025-06-30] DFND 0 385,511
Landscape Capital Management LLC [2025-06-30] DFND 372,533 372,533
BlackRock, Inc. [2025-06-30] SOLE 306,058 319,295
Two Sigma Advisers LP [2025-06-30] SOLE 260,100 269,600
Geode Capital Management LLC [2025-06-30] DFND 249,351 249,351
Two Sigma Investments LP [2025-06-30] SOLE 238,347 238,347
Morgan Stanley [2025-06-30] DFND 177,943 178,243
Landscape Capital Management LLC [2025-06-30] SOLE 122,863 122,863
State Street Corp [2025-06-30] DFND 87,002 87,002
Rangeley Capital LLC [2025-06-30] SOLE 65,000 65,000
UBS Group AG [2025-06-30] DFND 62,000 62,000
Bridgeway Capital Management LLC [2025-06-30] SOLE 59,900 59,900
Susquehanna International Group LLP [2025-06-30] OTR 45,320 45,320
Northern Trust Corp [2025-06-30] DFND 43,196 43,196
Captrust Financial Advisors [2025-06-30] SOLE 40,000 40,000
XTX Topco Ltd [2025-06-30] DFND 26,044 26,044
Integrated Wealth Concepts LLC [2025-06-30] SOLE 0 25,000
Private Advisor Group LLC [2025-06-30] SOLE 0 22,500
Schonfeld Strategic Advisors LLC [2025-06-30] SOLE 17,115 17,115
HRT Financial LP [2025-06-30] DFND 12,678 12,678
Citadel Advisors LLC [2025-06-30] DFND 12,497 12,497
Federated Hermes Inc [2025-06-30] DFND 12,237 12,237
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com